Drug: KALETRA Injury: Lipodystrophy acquired Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
71171719 | KALETRA | Lipodystrophy acquired | BRISTOL MYERS SQUIBB | 52.00 YR | M | 0 | 20160922 | US |
118757793 | KALETRA | Lipodystrophy acquired | GLAXOSMITHKLINE | 26.70 YR | M | 0 | 20160929 | JP |
118761913 | KALETRA | Lipodystrophy acquired | VIIV | 26.70 YR | M | 0 | 20160929 | JP |
125422481 | KALETRA | Lipodystrophy acquired | BRISTOL MYERS SQUIBB | 48.00 YR | M | 0 | 20160708 | JP |
126434631 | KALETRA | Lipodystrophy acquired | ROCHE | 54.00 YR | M | 0 | 20160811 | CA |
730262226 | KALETRA | Lipodystrophy acquired | MERCK | 52.00 YR | M | 0 | 20160923 | US |
Total Records: 6 Number of Pages: 1